# OnCo record geron (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/geron/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "geron" ;
  schema:name "Geron Corporation"@en ;
  schema:alternateName "Geron"@en ;
  schema:description "Geron is the Californian company behind imetelstat, the first telomerase inhibitor to reach approval, cleared by the FDA in 2024 for lower-risk myelodysplastic syndromes with transfusion-dependent anaemia."@en ;
  schema:url <https://onco.cc/companies/geron/>, <https://www.geron.com/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Geron_Corporation> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5552410> ;
  schema:citation <https://www.geron.com/>, <https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancer-hematologic-malignancies-approval-notifications> ;
  onco:tag "fda-oce-applicant" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/imetelstat/> ;
  onco:trials <https://onco.cc/trials/nct05583552/>, <https://onco.cc/trials/impactmf/> .